Achieve Life Sciences (ACHV) Short Interest
Nasdaq • ACHV • US0044685008
As of Oct 22, 2026, ORTEX estimated 25% of free float sold short, 12.9 days to cover, cost to borrow 1.5%. Sign up for live short interest data.
Nasdaq • ACHV • US0044685008
As of Oct 22, 2026, ORTEX estimated 25% of free float sold short, 12.9 days to cover, cost to borrow 1.5%. Sign up for live short interest data.
This page tracks how heavily Achieve Life Sciences (Nasdaq:ACHV) is being shorted: ORTEX's daily short interest estimate, the cost to borrow the shares, utilization of the lendable supply and days to cover, next to the official exchange-reported figure.
Source: ORTEX. Some figures are limited on the free view; live data and full history are part of ORTEX Advanced.
Achieve Life Sciences (Nasdaq: ACHV) has a market capitalization of $691.5M. Last close $6.72 (as of 2026-11-09); 52-week range $2.62 to $8.64. ORTEX data as of 2026-10-22: short interest was 24.96% of free float, 12.9 days to cover and the average cost to borrow was 1.5%. Sign up for live short interest data.